Skip to main content
Published locations for Tofacitinib more effective than tocilizumab in bDMARD-naïve patients with methotrexate-refractory RA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Tofacitinib more effective than tocilizumab in bDMARD-naïve patients with methotrexate-refractory RA
User login
Username
Password
Reset your password
/content/tofacitinib-more-effective-tocilizumab-bdmard-naive-patients-methotrexate-refractory-ra
/rheumatology/article/241418/rheumatoid-arthritis/tofacitinib-more-effective-tocilizumab-bdmard-naive